BNET Industries
Quest Diagnostics Inc. (DGX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $6.7B
- Profit
- Dec 31 2007
- $339.9M
- Market Cap
- Aug 19 2008
- $10.5B
Latest News and Analysis
15 Value Hedge Funds Portfolio Update
Mebane Faber submits: Are the top value hedge funds going to beat the market every quarter, or just outperform when the market is going up? Maybe we should ask Will Ferrell, errr, I mean Robert Goulet: by Mebane Faber
Highly Defensive PerformIdex: 35 Stocks to Outpace the Markets
Mike Havrilla submits: The accompanying table presents a quarterly update of my Highly Defensive PerformIdex, with an average beta of 0.72 and a market cap-weighted total return of 7.9% over the past year, outpacing the overall market and ETF peer group -- except for Vanguard Consumer Staples VDC ETF with...
Quest Diagnostics, Inc. Q2 2008 Earnings Call Transcript
Quest Diagnostics, Inc. DGX Q2 FY08 Earnings Call
Buying Gold for Oil Like George Soros
Arie Goren submits: On his column at Forbes.com on July 17, 2008, “Gold And Oil For Soros”, Robert Lenzner says that the legendary investor George Soros, Chairman of Soros Fund Management,“finally shorted oil at $137 a barrel and put on a long position in gold; he expects to see gold...
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
MADISON, N.J., June 3 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated today announced results of a study that demonstrates that a novel diagnostic testing technique it has developed is the first to provide direct, accurate and reproducible physical measurement of both the size and concentration of a broad range of...
Quest Diagnostics Selects Ericom's PowerTerm WebConnect for Centrally Managed Application Access
Leading diagnostic testing company to deploy Ericom's access solution to 17,000 users nationwide
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 21 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on July 18, 2008, to shareholders of...
Quest Diagnostics Chooses Roche's Fully Automated, Real-Time HIV-1 Viral Load Monitoring Test For Its Customers in Laboratories Nationwide
INDIANAPOLIS, May 19 /PRNewswire/ -- Roche Diagnostics today announced that Quest Diagnostics , the nation's leading provider of diagnostic testing, information and services, has signed a multi-year agreement to use the COBASR AmpliPrep / COBASR TaqManR HIV-1 Test for HIV viral load testing.
Quest Diagnostics and Google Empower Patients and Physicians to Share Diagnostic Test Results Online With Launch of Google Health
MADISON, N.J., May 19 /PRNewswire-FirstCall/ -- Patients and physicians have a new way to share diagnostic laboratory data online, thanks to Quest Diagnostics and Google Health, a product launched today by Google. More than 100,000 physicians in the U.S. who use Quest Diagnostics' family of Care360TM connectivity products...
Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles'
Company's "Biggest Loser" Bill Germanakos to Deliver NBGH Keynote Address
Quest Diagnostics Announces Annual Shareholder's Meeting Webcast
MADISON, N.J., May 12 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated , the leading provider of diagnostic testing, information and services, will conduct its annual meeting of shareholders on Friday, May 16th at 10:30 am ET.
QUEST DIAGNOSTICS
QUEST DIAGNOSTICS launched an interactive campaign touting its colorectal cancer screening services. The "Do you have the guts?" campaign features a website (doyouhavetheguts.com), including a "Happy healthy colon" viral video, and outreach to bloggers over 50, as well as to physicians and health plans. The somewhat surreal video, which viewers...
Quest Diagnostics, Inc. Q4 2007 Earnings Call Transcript
Quest Diagnostics, Inc. Q4 2007 Earnings Call Transcript
Quest Diagnostics Inc. Q1 2008 Earnings Call Transcript
Quest Diagnostics Inc. Q1 2008 Earnings Call Transcript
Research and Markets: Key New Analysis of Quest Diagnostics and Profiles of Their Major Competitors
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c89049) has announced the addition of "Analysis of Quest Diagnostics" to their offering.
Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
To: BUSINESS EDITORS To: BUSINESS EDITORS
Use of Methamphetamine Among U.S. Workers and Job Applicants Drops 22 Percent in 2007 and Cocaine Use Slows Dramatically, Reports Quest Diagnostics
The percentage of positive tests for methamphetamine among U.S. job applicants and workers in the general U.S. workforce dropped more than 22 percent between 2006 and 2007. These findings, from the Quest Diagnostics Drug Testing Index®, reflect the reversal of an upward trend in use of the drug by...
Quest Diagnostics, Inc. Q4 2007 Earnings Call Transcript
Quest Diagnostics, Inc. Q4 2007 Earnings Call Transcript
Humana Extends Agreements with LabCorp and Quest Diagnostics
New Contract for National Laboratory and Testing Services
Quest Diagnostics Q3 2007 Earnings Call Transcript
Quest Diagnostics Q3 2007 Earnings Call Transcript
- Next »
- page 1 of 5
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- Hackensack (10 results)
- finance (7 results)
- Call Transcript (6 results)
- Earnings (6 results)
- Seeking Alpha (6 results)
- Financial Accounting (6 results)
- company (4 results)
- New York Stock Exchange (4 results)
- Google Inc. (3 results)
- health care (3 results)
- stock (3 results)
- UnitedHealth Group Inc. (3 results)
- patient (3 results)
- CEO: Dr. Surya N. Mohapatra Ph.D.
Quest Diagnostics is a provider of diagnostic testing, information and related services. Co. provides patients and physicians access to diagnostic laboratory services through its nationwide network of laboratories and patient service centers. Co. also provides interpretive consultation through its medical and scientific staff across the U.S. In addition, Co. provides gene-based testing and other esoteric testing, anatomic pathology services, including dermatopathology, and testing for drugs-of-abuse, as well as testing for clinical trials, and risk assessment services for the life insurance industry. Additionally, Co. manufactures and markets diagnostic test kits and point-of-care testing.
Key Competitors
Quest Diagnostics Inc. Company Info
Board of Directors
Dr. Surya N. Mohapatra Ph.D.
Chairman
Mr. William F. Buehler
Ms. Rosanne Haggerty
Dr. Daniel C. Stanzione Ph.D.
Dr. Jenne K. Britell Ph.D.
Dr. Gail R. Wilensky Ph.D.
Mr. John B. Ziegler
Dr. John C. Baldwin
Mr. Gary M. Pfeiffer
Contact Information
1290 Wall Street West
Lyndhurst, NJ
http://www.questdiagnostics.com
201 393-5000